These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 29460465)

  • 1. A study on the effect of detector resolution on gamma index passing rate for VMAT and IMRT QA.
    Woon W; Ravindran PB; Ekayanake P; S V; Lim YY; Khalid J
    J Appl Clin Med Phys; 2018 Mar; 19(2):230-248. PubMed ID: 29460465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of volumetric modulated arc therapy patient specific QA results to multileaf collimator errors and correlation to dose volume histogram based metrics.
    Coleman L; Skourou C
    Med Phys; 2013 Nov; 40(11):111715. PubMed ID: 24320423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between gamma index passing rate and clinical dosimetric difference for pre-treatment 2D and 3D volumetric modulated arc therapy dosimetric verification.
    Jin X; Yan H; Han C; Zhou Y; Yi J; Xie C
    Br J Radiol; 2015 Mar; 88(1047):20140577. PubMed ID: 25494412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMRT QA and gamma comparisons: The impact of detector geometry, spatial sampling, and delivery technique on gamma comparison sensitivity.
    Steers JM; Fraass BA
    Med Phys; 2021 Sep; 48(9):5367-5381. PubMed ID: 34036596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of volumetric modulated arc therapy (VMAT) quality assurance (QA) systems: sensitivity analysis to machine errors.
    Liang B; Liu B; Zhou F; Yin FF; Wu Q
    Radiat Oncol; 2016 Nov; 11(1):146. PubMed ID: 27821135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial clinical experience with ArcCHECK for IMRT/VMAT QA.
    Aristophanous M; Suh Y; Chi PC; Whittlesey LJ; LaNeave S; Martel MK
    J Appl Clin Med Phys; 2016 Sep; 17(5):20-33. PubMed ID: 27685107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of MLC model parameters for Monaco using commercial diode arrays.
    Kinsella P; Shields L; McCavana P; McClean B; Langan B
    J Appl Clin Med Phys; 2016 Jul; 17(4):37-47. PubMed ID: 27455495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems.
    Hussein M; Rowshanfarzad P; Ebert MA; Nisbet A; Clark CH
    Radiother Oncol; 2013 Dec; 109(3):370-6. PubMed ID: 24100148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pretreatment VMAT quality assurance with the integral quality monitor (IQM) and electronic portal imaging device (EPID).
    Ghafarian M; Price M; Morales-Paliza M
    J Appl Clin Med Phys; 2021 Mar; 22(3):166-175. PubMed ID: 33596336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of error detection capabilities of phantom, EPID and MLC log file based IMRT QA methods.
    Defoor DL; Stathakis S; Roring JE; Kirby NA; Mavroidis P; Obeidat M; Papanikolaou N
    J Appl Clin Med Phys; 2017 Jul; 18(4):172-179. PubMed ID: 28585300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity of gamma-index method to the positioning errors of high-definition MLC in patient-specific VMAT QA for SBRT.
    Kim JI; Park SY; Kim HJ; Kim JH; Ye SJ; Park JM
    Radiat Oncol; 2014 Jul; 9():167. PubMed ID: 25070065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorrect dosimetric leaf separation in IMRT and VMAT treatment planning: Clinical impact and correlation with pretreatment quality assurance.
    Sjölin M; Edmund JM
    Phys Med; 2016 Jul; 32(7):918-25. PubMed ID: 27394690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of MLC error sensitivity of various commercial devices for VMAT pre-treatment quality assurance.
    Saito M; Sano N; Shibata Y; Kuriyama K; Komiyama T; Marino K; Aoki S; Ashizawa K; Yoshizawa K; Onishi H
    J Appl Clin Med Phys; 2018 May; 19(3):87-93. PubMed ID: 29500857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual volume-based 3D gamma indices for pretreatment VMAT QA.
    Yi J; Han C; Zheng X; Zhou Y; Deng Z; Xie C; Jin X; Jin F
    J Appl Clin Med Phys; 2017 May; 18(3):28-36. PubMed ID: 28318101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite QA for intensity-modulated radiation therapy using individual volume-based 3D gamma indices.
    Han C; Yu W; Zheng X; Zhou Y; Gong C; Xie C; Jin X
    J Radiat Res; 2018 Sep; 59(5):669-676. PubMed ID: 30085157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of the gamma index analysis as a verification method of volumetric modulated arc therapy plans.
    Park JM; Kim JI; Park SY; Oh DH; Kim ST
    Radiat Oncol; 2018 Sep; 13(1):175. PubMed ID: 30217163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.
    Stasi M; Bresciani S; Miranti A; Maggio A; Sapino V; Gabriele P
    Med Phys; 2012 Dec; 39(12):7626-34. PubMed ID: 23231310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to SBRT patient quality assurance using EPID-based real-time transit dosimetry : A step to QA with in vivo EPID dosimetry.
    Moustakis C; Ebrahimi Tazehmahalleh F; Elsayad K; Fezeu F; Scobioala S
    Strahlenther Onkol; 2020 Feb; 196(2):182-192. PubMed ID: 31925465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
    Zhen H; Nelms BE; Tome WA
    Med Phys; 2011 Oct; 38(10):5477-89. PubMed ID: 21992366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMRT QA: Selecting gamma criteria based on error detection sensitivity.
    Steers JM; Fraass BA
    Med Phys; 2016 Apr; 43(4):1982. PubMed ID: 27036593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.